JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2526
VanEck Morningstar Wide Moat ETF
MOAT
$11.5B
| $5.11M | ﹤0.01% |
107,131
+1,744
| +2% | +$82.6K |
2017 Q2
8 quarters
|
|
2527
Unitil
UTL
$933M
| $5.11M | ﹤0.01% |
85,482
+3,618
| +4% | +$206K |
2013 Q2
24 quarters
|
|
2528
Avient
AVNT
$3.81B
| $5.11M | ﹤0.01% |
167,714
+24,092
| +17% | +$675K |
2015 Q4
14 quarters
|
|
|
ABMD
2529
PUT
DELISTED
Abiomed Inc
ABMD
| $5.1M | ﹤0.01% |
+20,000
| New | +$5.31M |
2019 Q2
0 quarters
|
|
|
SMC
2530
Summit Midstream
SMC
$457M
| $5.09M | ﹤0.01% |
49,231
+16,905
| +52% | +$2.06M |
2013 Q2
24 quarters
|
|
|
PGRE
2531
DELISTED
Paramount Group
PGRE
| $5.09M | ﹤0.01% |
372,652
-185,425
| -33% | -$2.67M |
2014 Q4
18 quarters
|
|
2532
Valley National Bancorp
VLY
$7B
| $5.09M | ﹤0.01% |
485,565
+73,208
| +18% | +$750K |
2013 Q2
24 quarters
|
|
2533
Honda
HMC
$41.3B
| $5.09M | ﹤0.01% |
197,095
-43,181
| -18% | -$1.15M |
2013 Q2
24 quarters
|
|
2534
CALL
HDFC Bank
HDB
$115B
| $5.09M | ﹤0.01% |
158,000
+48,000
| +44% | +$1.45M |
2019 Q1
1 quarter
|
|
|
2535
PUT
HDFC Bank
HDB
$115B
| $5.09M | ﹤0.01% |
158,000
+48,000
| +44% | +$1.45M |
2019 Q1
1 quarter
|
|
2536
Medifast
MED
$129M
| $5.08M | ﹤0.01% |
39,497
+1,154
| +3% | +$160K |
2013 Q2
24 quarters
|
|
2537
Texas Capital Bancshares
TCBI
$4.04B
| $5.08M | ﹤0.01% |
83,154
+34,082
| +69% | +$2.07M |
2013 Q2
24 quarters
|
|
2538
KT
KT
$9.05B
| $5.07M | ﹤0.01% |
408,125
+62,047
| +18% | +$756K |
2017 Q2
8 quarters
|
|
2539
Cavco Industries
CVCO
$4.4B
| $5.07M | ﹤0.01% |
32,414
+8,280
| +34% | +$1.13M |
2015 Q4
14 quarters
|
|
2540
iShares Core S&P US Value ETF
IUSV
$27.5B
| $5.06M | ﹤0.01% |
90,110
+9,106
| +11% | +$507K |
2016 Q1
13 quarters
|
|
2541
Transportadora de Gas del Sur
TGS
$4.07B
| $5.05M | ﹤0.01% |
369,912
+51,207
| +16% | +$617K |
2017 Q3
7 quarters
|
|
2542
Innospec
IOSP
$2.43B
| $5.04M | ﹤0.01% |
57,097
+17,924
| +46% | +$1.51M |
2013 Q2
24 quarters
|
|
2543
FIVE9
FIVN
$2.49B
| $5.03M | ﹤0.01% |
99,310
-93,276
| -48% | -$4.73M |
2015 Q2
16 quarters
|
|
2544
Safety Insurance
SAFT
$1.53B
| $5.03M | ﹤0.01% |
53,563
+9,849
| +23% | +$916K |
2016 Q1
13 quarters
|
|
2545
Smith & Nephew
SNN
$11.2B
| $5.03M | ﹤0.01% |
116,504
-39,335
| -25% | -$1.63M |
2014 Q2
20 quarters
|
|
2546
Nu Skin
NUS
$231M
| $5.02M | ﹤0.01% |
103,834
+5,910
| +6% | +$301K |
2013 Q2
24 quarters
|
|
|
RETA
2547
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.02M | ﹤0.01% |
54,830
-2,794
| -5% | -$241K |
2016 Q2
12 quarters
|
|
2548
PENN Entertainment
PENN
$2.13B
| $5.02M | ﹤0.01% |
260,858
-937,386
| -78% | -$19M |
2015 Q1
17 quarters
|
|
2549
CALL
CME Group
CME
$97.2B
| $5M | ﹤0.01% |
25,800
| – | – |
2017 Q4
6 quarters
|
|
|
2550
PUT
CME Group
CME
$97.2B
| $5M | ﹤0.01% |
25,800
| – | – |
2017 Q4
6 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.